MSP Recovery (LIFW), which does business as LifeWallet, said Monday it has reached a pharmaceutical antitrust settlement of $3.1 million.
The company claimed that a manufacturer had increased the price of a drug in violation of antitrust laws. The settlement amount is expected to be collected in Q3, it said.
MSP Recovery shares rose more than 10% in premarket hours Monday.
Price: 0.2661, Change: +0.02, Percent Change: +10.64
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.